The Center for BRCA and Related Genes @DanaFarberBRCA
The Center for #BRCA and Related Genes at @DanaFarber helps uncover new treatments for patients with #BRCA and BRCA related cancers dana-farber.org/research/depar… Joined May 2022-
Tweets83
-
Followers97
-
Following33
-
Likes39
In the final OS & biomarker analysis reported at JCO Precision Oncology, an OS benefit with addition of ATR inhibitor berzosertib to gemcitabine was observed in tumors with negative or low ATM expression... Read more at ascopubs.org/doi/10.1200/PO…
@BCRFcure Scientific Director Dr. Judy Garber and BCRF investigators Drs. Ian Krop and Lori Pierce discussed the latest #BreastCancerResearch breakthroughs at the annual Palm Beach Hot Pink Luncheon and Symposium, which raised over $2 million for #BreastCancer research!
For #TrialTuesday, learn about @ALLIANCE_org A211801 (BRCA-P Study) led by .@judygarber5 @DanaFarber comparing denosumab to placebo to prevent #breastcancer in women with a BRCA1 germline mutation: bit.ly/Alliance-A2118… #NCI #NCORP #BCsm .@sistersnetwork .@NBCF .@BCTrials
New pub in @JCO_ASCO: Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant #Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early #BreastCancer. @judygarber5 pubmed.ncbi.nlm.nih.gov/38301187/
For #trialtuesday, #CCTI_DFCI presents new trial 23-600 led by @FilipaLynce. IDE161, a PARG inhibitor, targets HRD and BRCA mutations in ER+ breast, endometrial, colorectal, and head and neck with these mutations. Different from PARPi. @DanaFarber Visit: forms.office.com/r/kM7e6JVxre
@DFCI_BreastOnc is leading a phase II study of niraparib with dostarlimab therapy as neoadjuvant treatment for patients with BRCA-mutated #BreastCancer. For more information call 877-338-7425 or visit: dana-farber.org/clinical-trial…
Congrats @FilipaLynce on your new publication in AACR! "From serendipity to intention: development of brain penetrant PARP1 selective inhibitors" aacrjournals.org/clincancerres/…
We are so thankful to everyone who attended and for all the speakers, Dr. Brugge, @loreleimucci, @SohrabShah, Dr. Chang, @ScullyRalph, @jjonkers2, Dr. Ellisen, and @force4sue for presenting from their various expertise! Can't wait until next year #cbrgsymposium23
Our last speaker for the day is @force4sue, executive director of FORCE, talking about "Health literacy in research and other barriers to engaging people with inherited mutations in the clinical trial lifecycle" - a very import topic for
Next up is Dr. Leif Ellisen who is talking about "Haploinsufficient phenotypes of BRCA1/2-mutant breast tissue"
Next up to close out this session, is @jjonkers2 speaking on "Understanding and overcoming PARP inhibitor resistance" #cbrgsymposium23
Next up is @ScullyRalph discussing "Synthetic lethal interactions of BRCA1 in stalled-fork repair" #cbrgsymposium23
The afternoon session has begun with a lecture from Dr. David Chang, University of Glasgow, presenting on "DDR deficiency and replication stress as therapeutic targets for pancreatic cancer" #cbrgsymposium23
Our last speakers for the morning session is @SohrabShah who will speak on "Co-evolution of ovarian cancers and their tumor microenvironments" #cbrgsymposium23
Thank you so much @loreleimucci for your presentation on "Heritability and DNA repair genes in prostate cancer"
Our next speaker is @loreleimucci who is the Director of Cancer Epidemiology & Cancer Prevention Program within the Department of Epidemiology at the Harvard T.H. Chan School of Public Health (HSPH).
"KO out BRCA1 in mice halopinsufficient for BRCA1 showed accelerated tumorigenesis relative to KO in BRCA-WT mice under conditions where there was simultaneous induction of CRE-medicated BRCA1 deletion" - Dr. Joan Brugge
The Center for BRCA & Related Genes symposium is underway at the Jimmy Fund Auditorium! Our keynote speaker, Dr. Joan Brugge, is presenting on "Breast tumor evolution: Findings from analysis of human tissue and mouse models" #cbrgsymposium23
Our own Dr. Brian Wolpin joins an important panel discussion on early detection in pancreatic cancer hosted by @lustgartenfdn during Seeing Beyond: Lustgarten’s Pancreatic Cancer Research Symposium on Nov 15th. Sign up today: ms.spr.ly/6017978ph #PancreaticCancerAwarenes
We are just one week away from the Center for BRCA & Related Genes Scientific Symposium! Check out event information here: CBRGsymposium23.eventbrite.com
Wector @Wector18
15 Followers 290 Following bioinformatics DNA damage DNA repair genomics RNA-seq multi-omics data data analysis machine learning
DFCI Postdoctoral and.. @DFCI_PGA
88 Followers 133 Following Postdoctoral and Graduate Student Association at @DanaFarber Cancer Institute Since 2005
Ilana Schlam @IlanaSchlam
2K Followers 692 Following Breast medical oncologist @TuftsMedicalCtr | Tweets are my own and not medical advice
Ozgur Adibelli @AdibelliOzgur
14 Followers 1K Following
Carmen Calfa, MD @CarmenCalfa
3K Followers 2K Following Medical Director Clinical Operations, Cancer Survivorship Program; Breast Oncologist @SylvesterCancer, AD of Community Outreach. #WomenInMedicine tweets=my own
Dana-Farber’s CCTI @DanaFarber_CCTI
84 Followers 22 Following Pioneering cancer research for personalized treatments through innovative clinical trials @DanaFarber and @HarvardMed. Appts: 617-632-5620
Stefania Morganti, MD @StefiMorganti
248 Followers 471 Following Research Fellow 👩🏼⚕️🧬 @DanaFarber | @Harvard l @BroadInstitute | From @IEOufficiale | @LaStatale 🇮🇹 Breast Cancer, Liquid Biopsy, ctDNA
Aedin Culhane (@Aedin.. @AedinCulhane
4K Followers 3K Following Prof @MedicineAtUL, @LDCRC_UL Computational Oncology #bioinformatics, R @bioconductor, @eHealth4Cancer. Formerly @HarvardBiostats @DanaFarber. Tweets are my own
Thousade @thousade22959
120 Followers 1K Following
Jos Jonkers @jjonkers2
1K Followers 188 Following Breast cancer researcher, group leader at Oncode Institute and the Netherlands Cancer Institute
Michelle Swift @SwiftMichelleL
53 Followers 228 Following Postdoc @DanaFarber Cancer Institute | Studying DNA repair in the @ChowdhuryLab | PhD @DrexelMedicine @DrexelMCBG
NHS SW Genomic Medici.. @SWGenomics
1K Followers 2K Following Improving Healthcare Through Genomics - working together to embed Genomics into standard care for patients and families across the South West.
Yvonne Sherba @LifeOvrLynchSyn
8 Followers 47 Following Lynch Syndrome Previvor. Thriving through fears and uncertainties of a genetic cancer disorder. Life Over Lynch Syndrome.
Kathleen T @KathleenWyant
14 Followers 89 Following
خديجة عبدال.. @khadeija_a
137 Followers 255 Following أُؤْمن بقوة الكلمة وآثر الفراشة Medicinal Chemist, Master student at @s_disco_ Erasum Mundus' 22 #PROTAC #drug_discovery
Victoria Syth @VSyth
112 Followers 2K Following
crownwife @crownwife
4K Followers 5K Following Live Free or Die. God bless America. 🇺🇸 Plant corn, get corn. 🐄 Do right and fear no man. Fascinated by music, history and Appalachia. Dona Nobis Pacem.
. @bcth2l
0 Followers 40 Following
Kristin Rickrode @KMRickrode
2 Followers 93 Following
Joan Montero @JoanMonte
942 Followers 1K Following Associate Professor at University of Barcelona (Campus Clínic). Cell death, senescence and cancer precision medicine group. Former IBEC/DFCI/HMS researcher
Michele Palkovits @m_palkovits
18 Followers 157 Following
DrJeffreyPF @DrJeffreyPF
85 Followers 115 Following DFCI Oncology Fellow. Osler Residency Alum. Tweets are my own (if there are any tweets).
Asaf Maoz @asaf_maoz
1K Followers 3K Following Medical Oncologist @DanaFarber | @DanaFarber, @MGHCancerCenter, @BMCimRES alum| #hereditarycancer #immunology | Languages🇪🇸🇩🇪🇧🇷🇫🇷 +| Views mine | he/him
Annie Collier @anniecoll
104 Followers 438 Following Principal Scientist, Translational Medicine Oncology at Genentech | Former Stanford post-doc | PhD Indiana University | Dog Lover, Volleyballer, Hoosier
Bayram İlkhan @bayramilkhan
297 Followers 3K Following
Nitz @NoRegrets7006
27 Followers 60 Following Dont take life too seriously. Your only here once. Live for today cos tomorrows not promised. True Crime, Luther, GOT & Harry Potter. IT Project Manager
Kathrin Dvir, MD, M.S.. @DvirKathrin
654 Followers 1K Following London educated Cambridge trained MD| HemOnc @DanaFarber @StElizabethsMC| IM @MountSinaiMiami| Mother,Wife| exBig Pharma | Citizen of the🌎:🇺🇦🇮🇱🇬🇧🇨🇾🇺🇸
CuringCancerNetwork @CuringN
137 Followers 111 Following The Curing Cancer Network, created by Nat Pernick, M.D., seeks to substantially reduce cancer deaths, initially in the U.S., by sharing ideas, grants and more.
Dana-Farber’s Breas.. @DFCI_BreastOnc
4K Followers 334 Following Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425
Ritamariaagostino @Ritamariaagost3
5 Followers 112 Following
Giuliana D'Auria @DAuriaGiuliana
22 Followers 201 Following
Berkeley Philips @berkphi
0 Followers 793 Following
[email protected].. @Danillozos
1 Followers 36 Following
Ghazal Kango @GhazalKangoMD
96 Followers 99 Following Currently a Hematology Oncology Fellow at UMMC interest in breast and GU cancers
Shu Yazaki, MD, PhD @ShuYazaki
371 Followers 431 Following Reseach fellow @MSKCancerCenter | Medical Oncologist trained at National Cancer Center🇯🇵| interested in Breast, GYN cancer, Genome biology, Tumor immunology
Maria Woodward @mmanzaro
20 Followers 164 Following
寿司食べ放題 @onco89
85 Followers 926 Following 僻地生まれ。腫瘍内科医。 音楽asia pops好き R&BとHIP-HOP好き。 SIRUP、J Park、Diverseddie、zack tablo、kirinji, jamiroquai 、KPOP 好き。かしこくなりたい。ヨーロッパの歴史べんきょうちう
Kent Mouw @mouwlab
1K Followers 578 Following Radiation oncology physician-scientist @danafarber @brighamwomens Assistant Professor @harvardmed #DNArepair #bladdercancer #prostatecancer
Kazuki Nozawa @kazuki_nozawa
992 Followers 476 Following Medical oncologist. Interested in breast oncology, ADCs, novel agent & jazz, coffee. 腫瘍内科医/乳がん情報チャンネル「BC tube」 @BC_tube
Lisa M Guzzardi, RN @LguzzardiM
7K Followers 5K Following Fierce #PatientAdvocate providing up to date research for 3K+ consumers @ risk & clinicians #JournalClub #bcsm #gyncsm #PancChat #BRCA #hereditarycancer
Monte Shaheen @monte_shaheen
76 Followers 168 Following interested in Melanoma and DNA damage response
Tyler Weaver @tylermweaver1
808 Followers 2K Following Former grad student in the @MusselmanLab. Current Postdoc at KUMC in the @Freudlab. Studying DNA repair and chromatin.
Grace Ma @GraceMa_Boston
172 Followers 2K Following International Marketing Specialist @danafarber. @MassGeneralNews and @emersoncollege alumna. Love Bambi, Dumbo, and snow leopards. Views and tweets are my own.
Dana-Farber’s CCTI @DanaFarber_CCTI
84 Followers 22 Following Pioneering cancer research for personalized treatments through innovative clinical trials @DanaFarber and @HarvardMed. Appts: 617-632-5620
JOAN BRUGGE @BruggeMe
837 Followers 48 Following
Jos Jonkers @jjonkers2
1K Followers 188 Following Breast cancer researcher, group leader at Oncode Institute and the Netherlands Cancer Institute
Sohrab Shah @SohrabShah
4K Followers 260 Following Computational oncology, cancer genome scientist, single cell dynamics, Memorial Sloan Kettering Cancer Center. Views are my own.
Lorelei Mucci @loreleimucci
2K Followers 706 Following Mom, wife, dog lover, cancer epidemiologist, women in #prostatecancer | @hsphcancerepi @harvardchansph @df_hcc Tweets represent my own views
Sara Tolaney @stolaney1
10K Followers 621 Following Chief, Division of Breast Oncology @DanaFarber Tennis fan Mother of two teenage girls
Toni Choueiri, MD @DrChoueiri
36K Followers 480 Following Senior Executive & Chief GU Cancers @DanaFarber; Prof Medicine @HarvardMed; 2021 Giants of Cancer Award ⚽ lover; 🚲@PanMass, seen on @msnbc @cnn @TODAYshow @GMA
Harvard Med Postgradu.. @HMSPostgradCE
4K Followers 345 Following Programs and continuing education for physicians, researchers and health care providers, delivered by Harvard faculty.
Serena Nik-Zainal @SerenaNikZainal
8K Followers 651 Following Professor of Genomic Medicine | #NHS | needs regular snacks | delivers an effective roundhouse kick | Though she be but little, she is fierce
Chowdhury Lab @ChowdhuryLab
1K Followers 362 Following The Chowdhury lab studies #DSBrepair, #RadiationOncology & #microRNAs as biomarkers @Harvardmed @DanaFarber @BrighamWomens. Account managed by lab members.
Laurie Glimcher MD @LGlimcherMD
5K Followers 174 Following President and CEO @DanaFarber. A scientist, a physician, an educator, and also a mom & grandmom dedicated to extending & improving the lives of patients.
Kathleen Helen Burns @KathleenHBurns
4K Followers 5K Following Chair of Pathology @DanaFarber | Professor of Pathology @HarvardMed @broadinstitute | physician-scientist studying #transposons in disease
judy garber @judygarber5
633 Followers 68 Following Director of the Center for Cancer Genetics and Prevention, Dana-Farber Cancer Institute. Professor of Medicine at Harvard Medical School. https://t.co/qX2Q0GNrF8
Sharon B. Cantor @CantorLab
2K Followers 835 Following Professor studying DNA replication and role in cancer, chemoresistance, and developmental diseases
Roger Greenberg @RogerRogergr
3K Followers 2K Following The Greenberg lab investigates processes that affect genome integrity and how they influence human biology
Daniel Durocher @durocher1
4K Followers 907 Following Lunenfeld-Tanenbaum Research Institute & U of Toronto // Lab tweets @durocherlab // Founder of @RepareRx // DNA repair, Synthetic lethality, Induced proximity
liz swisher @SwisherLiz
1K Followers 877 Following Gynecologic oncologist, cancer researcher @SwisherLab, outdoor enthusiast. Assess your cancer risk at https://t.co/5WGzR0Ducn. She/her.
Filipa Lynce, MD, FAS.. @FilipaLynce
1K Followers 500 Following Breast Oncologist @ Dana-Farber Cancer Institute. Director, Dana Farber IBC Program. DFCI Center for BRCA and related genes. Alliance EO. Tweets are my own.
BasserBRCA @BasserBRCA
2K Followers 1K Following @PennCancer's Basser Center for BRCA serves as a unique resource for those affected by BRCA gene mutations to access expert-approved info, news, edu and support
NCI Treatment @NCItreatment
5K Followers 366 Following Official Twitter account of the Division of Cancer Treatment & Diagnosis, National Cancer Institute, part of @NIH. Privacy: https://t.co/3AAxhFf3tV
Clinical Cancer Resea.. @CCR_AACR
7K Followers 265 Following Follow Clinical Cancer Research for innovative clinical trials and precision medicine. Published by @AACR.
Geoffrey Shapiro MD P.. @GShapiroMDPhD
201 Followers 6 Following Director, Early Drug Development Center, @DanaFarber. Tweets are my own.
Jennifer Guerriero, P.. @JennGuerriero
4K Followers 1K Following Macrophage Enthusiast, @Brighamsurgery @DFCI_BreastOnc | #TheMyeloidNetwork Co-Founder | wife and motherx3 | views=mine
ASCO @ASCO
147K Followers 2K Following Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. Assoc tweets labeled #ASCOAdvocacy. RTs ≠ endorse.
JAMA Oncology @JAMAOnc
46K Followers 545 Following JAMA Oncology is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.
Dana-Farber News @DanaFarberNews
5K Followers 387 Following Your official source for @DanaFarber Cancer Institute news | Research, science, and innovation | Media requests: [email protected] or 617-632-4090
Dana-Farber’s Breas.. @DFCI_BreastOnc
4K Followers 334 Following Patient-centered care, clinical trials & translational research on breast cancer @DanaFarber and @HarvardMed. Appts: 877-442-3324, Clinical trials: 877-338-7425
Mass General Brigham @MassGenBrigham
23K Followers 799 Following Mass General Brigham is an integrated health care system, uniting great minds to solve the hardest problems in medicine for our communities and the world.
Harvard Medical Schoo.. @harvardmed
451K Followers 685 Following Official Twitter home of Harvard Medical School, featuring our advances in biomedical research, trends in medical education, and more.
Brigham and Women's H.. @BrighamWomens
59K Followers 3K Following Providing the news and latest research from Brigham and Women's Hospital in Boston, MA, a nonprofit teaching affiliate of Harvard Medical School.
The Jimmy Fund @TheJimmyFund
47K Followers 208 Following Since 1948, the Jimmy Fund has supported the fight against cancer in children and adults at Boston's @DanaFarber Cancer Institute. | https://t.co/Dcr4R0DRtn
Dana-Farber @DanaFarber
113K Followers 9K Following Dana-Farber Cancer Institute - a leading center for expert, compassionate cancer care and advanced research. Appts: 877-442-3324 | https://t.co/HvCwkLlticOur #staffhighlight today is Darren Dias, a program coordinator in the #CCTI_DFCI. He provides administrative support to our CCTI staff and plans, implements, and executes CCTI events. He loves Reese’s PB cups! @DanaFarber @DanaFarberNews
At #SGOMtg @DanaFarber's Betsy Lee, MD presented new research showing the combination of avelumab and axitinib produced promising results in a clinical trial involving patients with a hard-to-treat type of endometrial cancer. ➡️ ms.spr.ly/6012cWfos
@BCRFcure Scientific Director Dr. Judy Garber and BCRF investigators Drs. Ian Krop and Lori Pierce discussed the latest #BreastCancerResearch breakthroughs at the annual Palm Beach Hot Pink Luncheon and Symposium, which raised over $2 million for #BreastCancer research!
For #TrialTuesday, learn about @ALLIANCE_org A211801 (BRCA-P Study) led by .@judygarber5 @DanaFarber comparing denosumab to placebo to prevent #breastcancer in women with a BRCA1 germline mutation: bit.ly/Alliance-A2118… #NCI #NCORP #BCsm .@sistersnetwork .@NBCF .@BCTrials
A great visit to @AstraZeneca with @GShapiroMDPhD and @FilipaLynce a few weeks ago to talk about targeting #macrophages in breast cancer. Excited about new clinical trials! Who knows this chemical structure? Hint: It is our favorite class of drugs to study in the lab!
New pub in @JCO_ASCO: Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant #Olaparib in g BRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early #BreastCancer. @judygarber5 pubmed.ncbi.nlm.nih.gov/38301187/
For #trialtuesday, #CCTI_DFCI presents new trial 23-600 led by @FilipaLynce. IDE161, a PARG inhibitor, targets HRD and BRCA mutations in ER+ breast, endometrial, colorectal, and head and neck with these mutations. Different from PARPi. @DanaFarber Visit: forms.office.com/r/kM7e6JVxre
@DFCI_BreastOnc is leading a phase II study of niraparib with dostarlimab therapy as neoadjuvant treatment for patients with BRCA-mutated #BreastCancer. For more information call 877-338-7425 or visit: dana-farber.org/clinical-trial…
Really happy to share our latest paper out today @NatureSMB, where we describe a mechanism by which DYNLL1 evicts MRE11 from DSBs and regulates Shieldin complex recruitment. Congratulations to all the authors! 👏
The Gray Foundation has awarded $25 million to 7 research teams, 5 of which are based in Greater Boston, to fight BRCA-related cancers. "Boston is number one in terms of cancer research,” @LGlimcherMD said. “It’s an unbelievable life sciences ecosystem.” bostonglobe.com/2023/08/10/bus…
Great talk by @GShapiroMDPhD on pol theta inhibition in HRD cancers. Important collaboration between Alan d’Andrea and Geoff Shapiro’s labs that is being tested in the clinic. @DFCI_BreastOnc @DanaFarberBRCA @DanaFarber
Grateful for this great team focusing on DNA damage and immune activation in #breastcancer. #AACR2023 @FilipaLynce @GShapiroMDPhD Alan D’Andrea @DFCI_BreastOnc @DanaFarberBRCA @BrighamSurgery
Loved the chance to sit down with the legendary Dr. Chris Crum and discuss the many questions still needing answers in understanding ovarian cancer pathogenesis @UWashOBGYN @UWMedicine @DanaFarberBRCA
Join our @uwlabmedpath grand rounds today (3/1) via @Zoom from 1:30-2:30 PST! We're hosting Dr. Christopher Crum from @BWHPath/@harvardmed. His talk will focus on evolutionary pathways for serous tubal intraepithelial carcinoma (STIC) 🔬 #gyncsm #pathtwitter @UWashOBGYN @ISGynP
A New View of HER2 Expression | Join Drs. Tarantino, Schnitt and Reis-Filho on March 13 in Person or Online for this @PeerView Symposium ➡️Testing/Treatment Advice for #HER2Low #BreastCancer. Register here: PeerView.com/865/23HER2Low @PTarantinoMD @SchnittStuart
Drs. Massimo Cristofanilli and Sara Tolaney analyze a patient case of a 62-year-old woman with metastatic HR+ #breastcancer in Episode 5 of @OncLive's My Treatment Approach series. @stolaney1 @MCristofanill Watch the video here: onclive.com/view/patient-p…
A study led @DanaFarber’s @DrMatulonis that published today in @JCO_ASCO shows a novel conjugate therapy produced remissions in one-third of patients with drug-resistant ovarian cancer dana-farber.org/newsroom/news-…
👏Congratulations to our @DFCI_BreastOnc staff who were among those selected by Boston magazine for its 2023 list of Top Doctors! @bunnell_craig @DrHBurstein @judygarber5 @nlinmd @FilipaLynce @elmayermd @AnnPartridgeMD @dr_laurad @TariKingMD @jenniferbellon2 @SchnittStuart
Excited to share that LINE-1-encoded ORF1p, our "hallmark of cancer" is detectable in the peripheral blood. 🩸 A brilliant collaboration with the Walt lab @wyssinstitute @BWHPath and many generous colleagues @MGHCancerCenter @DanaFarber. biorxiv.org/cgi/content/sh…
Trends for United States
You might like
